General
Evolocumab plus statin potentially reduces atherosclerosis progression in GLAGOV study | News for Doctor, Nurse, Pharmacist | Cardiology | MIMS Malaysia
 

Evolocumab plus statin potentially reduces atherosclerosis progression in GLAGOV study | News for Doctor, Nurse, Pharmacist | Cardiology | MIMS Malaysia

Shared by:

 
Evolocumab plus statin potentially reduces atherosclerosis progression in GLAGOV study in American Heart Association (AHA) Scientific Sessions 2016 | MIMS Malaysia
 
specialty.mims.com
 
11 Sep 2017 - General